{"rows":[{"id":2132,"title":"Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.","authors":"Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2021-08-12","publication_year":2021,"doi":"10.3390/ph14080793","pubmed_id":"34451890","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34451890/","substance_tags":"psilocybin","topic_tags":"Depression,Meta-Analysis,Systematic Review,Review Article","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34451890","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34451890/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34451890","source_url":"https://pubmed.ncbi.nlm.nih.gov/34451890/","doi":"10.3390/ph14080793","pmid":"34451890","publication_date":"2021-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":1904,"title":"Rediscovering Psilocybin as an Antidepressive Treatment Strategy.","authors":"Zeiss R, Gahr M, Graf H","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2021-09-28","publication_year":2021,"doi":"10.3390/ph14100985","pubmed_id":"34681209","openalex_id":"https://openalex.org/W3204600425","source_url":"https://pubmed.ncbi.nlm.nih.gov/34681209/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34681209","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34681209/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34681209","source_url":"https://pubmed.ncbi.nlm.nih.gov/34681209/","doi":"10.3390/ph14100985","pmid":"34681209","publication_date":"2021-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":1882,"title":"Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.","authors":"Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2021-11-24","publication_year":2021,"doi":"10.3390/ph14121213","pubmed_id":"34959614","openalex_id":"https://openalex.org/W3215766429","source_url":"https://pubmed.ncbi.nlm.nih.gov/34959614/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Spirituality,Review Article,Safety,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:34959614","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34959614/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34959614","source_url":"https://pubmed.ncbi.nlm.nih.gov/34959614/","doi":"10.3390/ph14121213","pmid":"34959614","publication_date":"2021-11-24","importer_version":"2.1.3","text_redistributed":false}},{"id":1784,"title":"New Paradigms of Old Psychedelics in Schizophrenia.","authors":"Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2022-05-23","publication_year":2022,"doi":"10.3390/ph15050640","pubmed_id":"35631466","openalex_id":"https://openalex.org/W4282930656","source_url":"https://pubmed.ncbi.nlm.nih.gov/35631466/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Microdosing,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35631466","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35631466/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35631466","source_url":"https://pubmed.ncbi.nlm.nih.gov/35631466/","doi":"10.3390/ph15050640","pmid":"35631466","publication_date":"2022-05-23","importer_version":"2.1.3","text_redistributed":false}},{"id":1616,"title":"A Review of Synthetic Access to Therapeutic Compounds Extracted from.","authors":"Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2022-12-28","publication_year":2022,"doi":"10.3390/ph16010040","pubmed_id":"36678537","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36678537/","substance_tags":"psilocybin,psilocin","topic_tags":"Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36678537","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36678537/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36678537","source_url":"https://pubmed.ncbi.nlm.nih.gov/36678537/","doi":"10.3390/ph16010040","pmid":"36678537","publication_date":"2022-12-28","importer_version":"2.1.3","text_redistributed":false}},{"id":1615,"title":"Psilocybin for Depression: From Credibility to Feasibility, What's Missing?","authors":"Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2022-12-31","publication_year":2022,"doi":"10.3390/ph16010068","pubmed_id":"36678564","openalex_id":"https://openalex.org/W4313471532","source_url":"https://pubmed.ncbi.nlm.nih.gov/36678564/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36678564","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36678564/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36678564","source_url":"https://pubmed.ncbi.nlm.nih.gov/36678564/","doi":"10.3390/ph16010068","pmid":"36678564","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}},{"id":963,"title":"Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.","authors":"Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2024-11-05","publication_year":2024,"doi":"10.3390/ph17111484","pubmed_id":"39598395","openalex_id":"https://openalex.org/W4404077742","source_url":"https://pubmed.ncbi.nlm.nih.gov/39598395/","substance_tags":"psilocybin","topic_tags":"Addiction,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39598395","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39598395/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39598395","source_url":"https://pubmed.ncbi.nlm.nih.gov/39598395/","doi":"10.3390/ph17111484","pmid":"39598395","publication_date":"2024-11-05","importer_version":"2.1.3","text_redistributed":false}},{"id":854,"title":"Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.","authors":"Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2025-01-19","publication_year":2025,"doi":"10.3390/ph18010130","pubmed_id":"39861191","openalex_id":"https://openalex.org/W4406629036","source_url":"https://pubmed.ncbi.nlm.nih.gov/39861191/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39861191","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39861191/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39861191","source_url":"https://pubmed.ncbi.nlm.nih.gov/39861191/","doi":"10.3390/ph18010130","pmid":"39861191","publication_date":"2025-01-19","importer_version":"2.1.3","text_redistributed":false}},{"id":770,"title":"LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.","authors":"Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C, Cameron M, Zahoruiko Y, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2025-03-23","publication_year":2025,"doi":"10.3390/ph18040451","pubmed_id":"40283890","openalex_id":"https://openalex.org/W4408792078","source_url":"https://pubmed.ncbi.nlm.nih.gov/40283890/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Animal Study,Inflammation","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:01","bibtex":null,"source_record_id":"PMID:40283890","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40283890/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40283890","source_url":"https://pubmed.ncbi.nlm.nih.gov/40283890/","doi":"10.3390/ph18040451","pmid":"40283890","publication_date":"2025-03-23","importer_version":"2.1.3","text_redistributed":false}},{"id":745,"title":"The Emergence of Psilocybin in Psychiatry and Neuroscience.","authors":"Omidian H, Omidian A","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2025-04-09","publication_year":2025,"doi":"10.3390/ph18040555","pubmed_id":"40283990","openalex_id":"https://openalex.org/W4409313347","source_url":"https://pubmed.ncbi.nlm.nih.gov/40283990/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40283990","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40283990/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40283990","source_url":"https://pubmed.ncbi.nlm.nih.gov/40283990/","doi":"10.3390/ph18040555","pmid":"40283990","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":619,"title":"Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.","authors":"Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2025-07-01","publication_year":2025,"doi":"10.3390/ph18070989","pubmed_id":"40732278","openalex_id":"https://openalex.org/W4411961287","source_url":"https://pubmed.ncbi.nlm.nih.gov/40732278/","substance_tags":"psilocybin,psilocin","topic_tags":"Review Article,Observational Study","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40732278","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40732278/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40732278","source_url":"https://pubmed.ncbi.nlm.nih.gov/40732278/","doi":"10.3390/ph18070989","pmid":"40732278","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":272,"title":"Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.","authors":"Dolenec P, Pelčić G, Pilipović K, Mršić-Pelčić J, Hrkać AH","journal":"Pharmaceuticals (Basel, Switzerland)","publication_date":"2026-02-14","publication_year":2026,"doi":"10.3390/ph19020316","pubmed_id":"41754856","openalex_id":"https://openalex.org/W7128923372","source_url":"https://pubmed.ncbi.nlm.nih.gov/41754856/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Mechanism of Action,Oxidative Stress,Review Article,Animal Study,Toxicity,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41754856","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41754856/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41754856","source_url":"https://pubmed.ncbi.nlm.nih.gov/41754856/","doi":"10.3390/ph19020316","pmid":"41754856","publication_date":"2026-02-14","importer_version":"2.1.3","text_redistributed":false}}],"total":12,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Pharmaceuticals (Basel, Switzerland)","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}